Posted On: 04/21/2014 10:26:23 PM
Post# of 273318
Nasdaq Biotechnology Ishares (IBB) 227.34 $IBB
What to Watch for in Biotech Earnings This Week
George Budwell, The Motley Fool - Motley Fool - Mon Apr 21, 5:30PM CDT
Biotech stocks started the year off on a tear but have moved lower lately in dramatic fashion. For instance, the iShares Nasdaq Biotech Index is now down over 2% for the year, after gaining double digits at one point in early February. Pundits and...
iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 2.33%
Comtex SmarTrend(R) - Mon Apr 21, 3:55PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $221.37 to a high of $227.34. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $226.39 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
4 Reasons You Should Watch This Under-the-Radar Stock on Your Watchlist
George Budwell, The Motley Fool - Motley Fool - Fri Apr 18, 5:30PM CDT
The ongoing market correction has taken a serious toll on biotech stocks, especially among companies early in their development. The iShares Nasdaq Biotech Index , for instance, is down over 15% in the past month alone. Market corrections (and bull...
'Fast Money' Recap: Watch Where Bonds Are Headed
at The Street - Fri Apr 18, 4:00AM CDT
The trading panel discussed bonds, industrial stocks, Chipotle Mexican Grill and IBM.
Biotech Bubble Bust: 2 Ways to Win
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Tue Apr 15, 1:08PM CDT
Are biotech stocks in a bubble? Is that bubble collapsing? These are the two questions at the forefront of investors' minds. Given the tremendous run of biotech stocks, the iShares NASDAQ Biotechnology Index is up 80% over the last 2 years, it's...
IBB, CELG, BIIB, ALXN: ETF Inflow Alert
ETFChannel.com - Tue Apr 15, 10:15AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Nasdaq Biotechnology ETF where we have detected an approximate $290.9 million dollar inflow -- that's a 6.9%...
Are Biotechs Bad Medicine for the S&P 500?
George Budwell, The Motley Fool - Motley Fool - Tue Apr 15, 8:30AM CDT
The S&P 500 is a closely watched indicator of the U.S. economy that has started to falter over the past few weeks. Specifically, the S&P 500 is now down over 2% in the last month, although it's still up about 15% over the last year....
3 Biotech Stocks Falling Like a Knife: Puma Biotechnology, MacroGenics, and Aratana Therapeutics
George Budwell, The Motley Fool - Motley Fool - Mon Apr 14, 1:30PM CDT
Biotech stocks have been in near free-fall the past month, with the iShares Nasdaq Biotechnology Index dropping a noteworthy 15.4%. While this could be part of a general market correction, such a dramatic decline may indicate deeper issues with...
iShares Nasdaq Biotechnology Index Down 14.9% Since SmarTrend Downtrend Call (IBB)
Comtex SmarTrend(R) - Mon Apr 14, 11:10AM CDT
SmarTrend identified a Downtrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on March 10th, 2014 at $258.23. In approximately 1 month, iShares Nasdaq Biotechnology Index has returned 14.86% as of today's recent price of $219.85.
Capitulation Next Week? Or a Bounce to Sell Into Now?
at The Street - Mon Apr 14, 10:37AM CDT
Prepare yourself for more downside even if we do bounce next week.
'Fast Money' Recap: The Skid Continues
at The Street - Sat Apr 12, 4:00AM CDT
The trading panel looked at General Motors and wondered how low it can go.
Stocks Revisit Session Lows; Share Offer Lifts GasLog
at Investor's Business Daily - Fri Apr 11, 2:03PM CDT
Selling picked up pace Friday afternoon as Wall Street weighed earnings reports in the financial sector and a better-than-expected reading on consumer confidence. The Nasdaq slumped 1.1%. The Dow Jones industrial average and S&P 500 each fell 0.8%....
Jim Cramer's Mad Dash: HRB GILD
at The Street - Fri Apr 11, 9:38AM CDT
The tax man cometh and shows no sign of leaving, which means good news for H&R Block as it spins off its banking division, Cramer says.
Inside the Wild Ride of Biotech ETFs - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Fri Apr 11, 9:01AM CDT
Biotech ETFs have been crashing, but have all the funds been performing the same in the space?
Today's Biotech Stocks to Watch: AbbVie Inc., Enanta Pharmaceuticals Inc. and Gilead Sciences
George Budwell, The Motley Fool - Motley Fool - Fri Apr 11, 7:57AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for AbbVie , Enanta Pharmaceuticals and Gilead Sciences AbbVie and Enanta presented additional data from two late-stage studies dubbed SAPPHIRE-I and...
Stock Market Volatility: Here's What's Happening
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Fri Apr 11, 7:40AM CDT
After two consecutive winning days brought U.S. stocks back to within 1% of their all-time high, the major indexes suffered bruising losses on Thursday, with the benchmark S&P 500 and the narrower Dow Jones Industrial Average losing 2.1% and...
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 5.61% Sell Off
Comtex SmarTrend(R) - Thu Apr 10, 3:48PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $219.69 to a high of $234.57. Yesterday, the shares fell 5.6%, which took the trading range below the 3-day low of $221.18 on volume of 4.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
iShares Nasdaq Biotechnology Index Falls 5.61% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Apr 10, 3:48PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $219.69 to a high of $234.57. Yesterday, the shares fell 5.6%, which took the trading range below the 3-day low of $221.18 on volume of 4.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
What to Watch for in Biotech Earnings This Week
George Budwell, The Motley Fool - Motley Fool - Mon Apr 21, 5:30PM CDT
Biotech stocks started the year off on a tear but have moved lower lately in dramatic fashion. For instance, the iShares Nasdaq Biotech Index is now down over 2% for the year, after gaining double digits at one point in early February. Pundits and...
iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 2.33%
Comtex SmarTrend(R) - Mon Apr 21, 3:55PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $221.37 to a high of $227.34. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $226.39 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
4 Reasons You Should Watch This Under-the-Radar Stock on Your Watchlist
George Budwell, The Motley Fool - Motley Fool - Fri Apr 18, 5:30PM CDT
The ongoing market correction has taken a serious toll on biotech stocks, especially among companies early in their development. The iShares Nasdaq Biotech Index , for instance, is down over 15% in the past month alone. Market corrections (and bull...
'Fast Money' Recap: Watch Where Bonds Are Headed
at The Street - Fri Apr 18, 4:00AM CDT
The trading panel discussed bonds, industrial stocks, Chipotle Mexican Grill and IBM.
Biotech Bubble Bust: 2 Ways to Win
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Tue Apr 15, 1:08PM CDT
Are biotech stocks in a bubble? Is that bubble collapsing? These are the two questions at the forefront of investors' minds. Given the tremendous run of biotech stocks, the iShares NASDAQ Biotechnology Index is up 80% over the last 2 years, it's...
IBB, CELG, BIIB, ALXN: ETF Inflow Alert
ETFChannel.com - Tue Apr 15, 10:15AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Nasdaq Biotechnology ETF where we have detected an approximate $290.9 million dollar inflow -- that's a 6.9%...
Are Biotechs Bad Medicine for the S&P 500?
George Budwell, The Motley Fool - Motley Fool - Tue Apr 15, 8:30AM CDT
The S&P 500 is a closely watched indicator of the U.S. economy that has started to falter over the past few weeks. Specifically, the S&P 500 is now down over 2% in the last month, although it's still up about 15% over the last year....
3 Biotech Stocks Falling Like a Knife: Puma Biotechnology, MacroGenics, and Aratana Therapeutics
George Budwell, The Motley Fool - Motley Fool - Mon Apr 14, 1:30PM CDT
Biotech stocks have been in near free-fall the past month, with the iShares Nasdaq Biotechnology Index dropping a noteworthy 15.4%. While this could be part of a general market correction, such a dramatic decline may indicate deeper issues with...
iShares Nasdaq Biotechnology Index Down 14.9% Since SmarTrend Downtrend Call (IBB)
Comtex SmarTrend(R) - Mon Apr 14, 11:10AM CDT
SmarTrend identified a Downtrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on March 10th, 2014 at $258.23. In approximately 1 month, iShares Nasdaq Biotechnology Index has returned 14.86% as of today's recent price of $219.85.
Capitulation Next Week? Or a Bounce to Sell Into Now?
at The Street - Mon Apr 14, 10:37AM CDT
Prepare yourself for more downside even if we do bounce next week.
'Fast Money' Recap: The Skid Continues
at The Street - Sat Apr 12, 4:00AM CDT
The trading panel looked at General Motors and wondered how low it can go.
Stocks Revisit Session Lows; Share Offer Lifts GasLog
at Investor's Business Daily - Fri Apr 11, 2:03PM CDT
Selling picked up pace Friday afternoon as Wall Street weighed earnings reports in the financial sector and a better-than-expected reading on consumer confidence. The Nasdaq slumped 1.1%. The Dow Jones industrial average and S&P 500 each fell 0.8%....
Jim Cramer's Mad Dash: HRB GILD
at The Street - Fri Apr 11, 9:38AM CDT
The tax man cometh and shows no sign of leaving, which means good news for H&R Block as it spins off its banking division, Cramer says.
Inside the Wild Ride of Biotech ETFs - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Fri Apr 11, 9:01AM CDT
Biotech ETFs have been crashing, but have all the funds been performing the same in the space?
Today's Biotech Stocks to Watch: AbbVie Inc., Enanta Pharmaceuticals Inc. and Gilead Sciences
George Budwell, The Motley Fool - Motley Fool - Fri Apr 11, 7:57AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for AbbVie , Enanta Pharmaceuticals and Gilead Sciences AbbVie and Enanta presented additional data from two late-stage studies dubbed SAPPHIRE-I and...
Stock Market Volatility: Here's What's Happening
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Fri Apr 11, 7:40AM CDT
After two consecutive winning days brought U.S. stocks back to within 1% of their all-time high, the major indexes suffered bruising losses on Thursday, with the benchmark S&P 500 and the narrower Dow Jones Industrial Average losing 2.1% and...
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 5.61% Sell Off
Comtex SmarTrend(R) - Thu Apr 10, 3:48PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $219.69 to a high of $234.57. Yesterday, the shares fell 5.6%, which took the trading range below the 3-day low of $221.18 on volume of 4.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
iShares Nasdaq Biotechnology Index Falls 5.61% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Apr 10, 3:48PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $219.69 to a high of $234.57. Yesterday, the shares fell 5.6%, which took the trading range below the 3-day low of $221.18 on volume of 4.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
(0)
(0)
